Skip to content

APOTHEEK CANDIDE JACOBS

Active
Private limited companyfounded 1991active for 34 yearsDriftweg 7, 8420 De Haan, BelgiumKBO/BCE: BE 0446.153.874
Summary

APOTHEEK CANDIDE JACOBS has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €81,383 and a net result of €88,669. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 26% of 12,686 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €1.1mturnover 2025, estimated
Staff
2.6 FTE
Equity
€81,383
Profit
€88,669
Turnover estimated from the gross margin
Financial health
85 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
CANDICO · 100%
2025 accounts 86 days early1 of 3 deeds summarised
Why 85raises riskSector: Retail trade (NACE 47)Equity €81,383 (15.8% of total assets)lowers riskLiquidity: current ratio 1.17, cash €181,179Founded in 1991Show the evidence

Checked score

Score 2025
85 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 52% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 41-2
equity 15.8% of total assets
Liquidity 48+10
short-term debt 83.8% · cash 35.1%
Profitability 90=
return on assets 17.2%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,248 companies, NACE 47, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024lowest value 01-2025: 0.4%▲ +0.1 percentage points vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.5%▲ +0.1 percentage points vs 03-2025highest value 05-2025: 0.4%▼ -0.1 percentage points vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.3%▼ -0.1 percentage points vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €6,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.17, compared with 1.19 in 2024, below the usual 1.5; short-term debt: 83.8% and cash: 35.1% of total assets), and 84.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 32% on solvency, 47% on liquidity, 85% on profitability and 42% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Equity €81,383 (15.8% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.17, cash €181,179
NBB · annual accounts
lowers risk · Founded in 1991
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 03-02-2026, 86 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
86 days early
2024
on the day
2023
1 day early
2022
12 days early
2021
2 days early
2020
9 days early
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 20 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 28 April (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end28-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Highest result from 2019 to 2025net €88,669 ▲14.4%
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Controlled by CANDICO 100% View
  • Positive: 7 profitable years in a rowprofit 2025: €88,669 7 years View

By topic

Financials

Financial year
2025
Total assets
€515,835
Profit
€88,669
Solvency
15.8%
Total assets▲ 13.2%
Net result
20192025
Go to Financials

Timeline

Events
35
Since
1993
Next accounts
by 30-04-2027
  1. 29-04-2024Annual accounts filed
  2. 13-09-2023Permanent representative: Candide Mariette Clement Marguerite Chantal…
  3. 18-04-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
30-12-1991
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Key facts about APOTHEEK CANDIDE JACOBS

What is the company number of APOTHEEK CANDIDE JACOBS?
0446.153.874. In Belgium the VAT number is the company number with BE in front: BE 0446.153.874.
Where is APOTHEEK CANDIDE JACOBS based?
The registered office is at Driftweg 7, 8420 De Haan.Company details
What does APOTHEEK CANDIDE JACOBS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK CANDIDE JACOBS?
Private limited company (BV).
When was APOTHEEK CANDIDE JACOBS founded?
On 30-12-1991.
Is APOTHEEK CANDIDE JACOBS still active?
Yes, APOTHEEK CANDIDE JACOBS is an active enterprise in the KBO register.
How many employees does APOTHEEK CANDIDE JACOBS have?
On average 2.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK CANDIDE JACOBS?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK CANDIDE JACOBS profitable?
In financial year 2025, APOTHEEK CANDIDE JACOBS made a profit of €88,669.
Where can I find the annual accounts of APOTHEEK CANDIDE JACOBS?
APOTHEEK CANDIDE JACOBS filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK CANDIDE JACOBS due?
By 30-04-2027, for financial year 2026.Timeline

Companies related to APOTHEEK CANDIDE JACOBS

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.